Complete remission of Hodgkin Lymphoma after a concurrent infection with COVID-19: systematic review and meta-analysis
Through December 2019, novel coronavirus (SARS-CoV-2) pneumonia (COVID-19) was reported in Wuhan and has since rapidly spread throughout China. Hodgkin lymphoma represents a heterogeneous hematological malignancy, which is characterized by immunosuppression. There are no clearly defined risk factors...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Al Muthanna University
2022-09-01
|
Series: | Muthanna Medical Journal |
Subjects: | |
Online Access: | https://muthmj.mu.edu.iq/wp-content/uploads/2022/07/Complete-remission-of-Hodgkin-Lymphoma-after-a-concurrent-infection-with-COVID-19-systematic-review-and-meta-analysis.pdf |